Melqart Asset Management (Uk) LTD Seagen Inc. Transaction History

Melqart Asset Management (Uk) LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $103,415 - $116,726	540 Added 0.1%	533,633 $113 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $59.7 Million - $65.7 Million	318,385 Added 148.29%	533,093 $103 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $27.4 Million - $43.6 Million	214,708 New	214,708 $43.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Melqart Asset Management (Uk) LTD, based on Form 13F filings with the SEC.

Stay updated on Melqart Asset Management (Uk) LTD with notifications on news.